Lianbio Stock Performance

LIANY Stock   0.1  0.01  6.52%   
LianBio holds a performance score of 11 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 0.13, which conveys not very significant fluctuations relative to the market. As returns on the market increase, LianBio's returns are expected to increase less than the market. However, during the bear market, the loss of holding LianBio is expected to be smaller as well. Use LianBio jensen alpha and the relationship between the potential upside and relative strength index , to analyze future returns on LianBio.

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in LianBio are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, LianBio showed solid returns over the last few months and may actually be approaching a breakup point. ...more
  

LianBio Relative Risk vs. Return Landscape

If you would invest  5.40  in LianBio on October 2, 2025 and sell it today you would earn a total of  4.40  from holding LianBio or generate 81.48% return on investment over 90 days. LianBio is currently producing 1.4199% returns and takes up 9.7959% volatility of returns over 90 trading days. Put another way, 87% of traded pink sheets are less volatile than LianBio, and 72% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon LianBio is expected to generate 13.56 times more return on investment than the market. However, the company is 13.56 times more volatile than its market benchmark. It trades about 0.14 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.09 per unit of risk.

LianBio Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for LianBio's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as LianBio, and traders can use it to determine the average amount a LianBio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1449

Best PortfolioBest Equity
Good Returns
Average ReturnsLIANY
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns
Based on monthly moving average LianBio is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of LianBio by adding it to a well-diversified portfolio.

Things to note about LianBio performance evaluation

Checking the ongoing alerts about LianBio for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for LianBio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
LianBio is way too risky over 90 days horizon
LianBio has some characteristics of a very speculative penny stock
LianBio appears to be risky and price may revert if volatility continues
Evaluating LianBio's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate LianBio's pink sheet performance include:
  • Analyzing LianBio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether LianBio's stock is overvalued or undervalued compared to its peers.
  • Examining LianBio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating LianBio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of LianBio's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of LianBio's pink sheet. These opinions can provide insight into LianBio's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating LianBio's pink sheet performance is not an exact science, and many factors can impact LianBio's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for LianBio Pink Sheet Analysis

When running LianBio's price analysis, check to measure LianBio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LianBio is operating at the current time. Most of LianBio's value examination focuses on studying past and present price action to predict the probability of LianBio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LianBio's price. Additionally, you may evaluate how the addition of LianBio to your portfolios can decrease your overall portfolio volatility.